CELTF(CELTF)
CELTF
No analyst ratings available
No analyst price targets available for CELTF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.18B | $1.38B | $1.28B |
| Low | $1.18B | $1.38B | $1.28B |
| High | $1.18B | $1.38B | $1.28B |
| EBITDA Avg | $539M | $630M | $585M |
| Low | $539M | $630M | $585M |
| High | $539M | $630M | $585M |
| EBIT Avg | $316M | $369M | $343M |
| Low | $316M | $369M | $343M |
| High | $316M | $369M | $343M |
| Net Income Avg | $245M | $390M | $241M |
| Low | $245M | $390M | $241M |
| High | $245M | $390M | $241M |
| EPS Avg | $0.21 | $0.33 | $0.20 |
| Low | $0.21 | $0.33 | $0.20 |
| High | $0.21 | $0.33 | $0.20 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $418M | $460M | $550M | $637M | $566M | $549M | $526M | $534M |
| Low | $418M | $460M | $550M | $637M | $566M | $549M | $526M | $534M |
| High | $418M | $460M | $550M | $637M | $566M | $549M | $526M | $534M |
| EBITDA Avg | $191M | $210M | $251M | $291M | $258M | $251M | $240M | $244M |
| Low | $191M | $210M | $251M | $291M | $258M | $251M | $240M | $244M |
| High | $191M | $210M | $251M | $291M | $258M | $251M | $240M | $244M |
| EBIT Avg | $112M | $123M | $147M | $170M | $151M | $147M | $141M | $143M |
| Low | $112M | $123M | $147M | $170M | $151M | $147M | $141M | $143M |
| High | $112M | $123M | $147M | $170M | $151M | $147M | $141M | $143M |
| Net Income Avg | $71M | $106M | $141M | $141M | $94M | $82M | $68M | $59M |
| Low | $71M | $106M | $141M | $141M | $94M | $82M | $68M | $59M |
| High | $71M | $106M | $141M | $141M | $94M | $82M | $68M | $59M |
| EPS Avg | $0.06 | $0.09 | $0.12 | $0.12 | $0.08 | $0.07 | $0.06 | $0.05 |
| Low | $0.06 | $0.09 | $0.12 | $0.12 | $0.08 | $0.07 | $0.06 | $0.05 |
| High | $0.06 | $0.09 | $0.12 | $0.12 | $0.08 | $0.07 | $0.06 | $0.05 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |